Article Text
Editorial
Metabolic modulation in heart failure: high time for a definitive clinical trial
Statistics from Altmetric.com
Footnotes
Linked articles 208751.
Funding The authors acknowledge funding by the British Heart Foundation and the NIHR Oxford Biomedical Research Centre.
Competing interests HA has in partnership successfully applied for method of use patents for the use of perhexiline in heart failure and cardiomyopathies.
Provenance and peer review Commissioned; externally peer reviewed.